InvestorsHub Logo
Followers 15
Posts 2477
Boards Moderated 0
Alias Born 03/09/2017

Re: peteypickem post# 13702

Monday, 06/26/2017 9:26:27 AM

Monday, June 26, 2017 9:26:27 AM

Post# of 50157
Waiting to get back in @ .05.

Their tests are promising but... too much debt and no FDA approval in the near future. Phase III will be very very expensive not to mention FDA fees for approval post phase III. This stock has more potential for buyout than FDA approval.

GLTY
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News